Helius Medical Technologies
13F holders, Q2 2024 (June 30)15holders +4
6new positions
2sold out
$0.98avg. 13F price*
At the end of Q2 2024, 15 institutions reported holding Helius Medical Technologies in their 13F filings, up 4 from Q1 2024. 6 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($127K), Susquehanna International Group, LLP ($16K) and Geode Capital Management, LLC ($14K).
- Company
- Helius Medical Technologies
- CUSIP
- 42328V801
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $160K |
| Exits | 2 | $64K |
All 13F filers, Q1 2024 → Q2 2024: 168,372 shares bought and 11,086 shares sold, net +157,286 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Armistice Capital, LLC | 0.00% | New | 130,000 | $127K |
| Susquehanna International Group, LLP | 0.00% | New | 16,260 | $16K |
| Geode Capital Management, LLC | 0.00% | New | 14,610 | $14K |
| Vanguard Group Inc. | 0.00% | No change | 12,598 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +589.0% | 6,904 | $7K |
| UBS Group AG | 0.00% | New | 1,549 | $2K |
| American Capital Advisory, LLC | 0.00% | New | 31 | $250 |
| CoreCap Advisors, LLC | 0.00% | No change | 200 | $196 |
| Osaic Holdings, Inc. | 0.00% | Reduce -4.8% | 80 | $78 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 37 | $36 |
| Bank of America Corp. | 0.00% | New | 20 | $20 |
| Toronto Dominion Bank | 0.00% | No change | 7 | $7 |
| Morgan Stanley | 0.00% | No change | 4 | $4 |
| St Germain D J Co. Inc. | 0.00% | No change | 2 | $2 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is HELIUS MEDICAL TECHNOLOGIES's weight in each manager's 13F, not the share of Helius Medical Technologies the manager owns.